List of Tables
Table 1. Global Targeted Radiopharmaceuticals Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Targeted Radiopharmaceuticals Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Targeted Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2024
Table 4. Global Targeted Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Targeted Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Targeted Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Targeted Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Targeted Radiopharmaceuticals Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Targeted Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Targeted Radiopharmaceuticals, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Targeted Radiopharmaceuticals, Product Type & Application
Table 12. Global Key Manufacturers of Targeted Radiopharmaceuticals, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeted Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radiopharmaceuticals as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Targeted Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Targeted Radiopharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 18. Global Targeted Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 19. Global Targeted Radiopharmaceuticals Sales by Region (2026-2031) & (K Units)
Table 20. Global Targeted Radiopharmaceuticals Sales Market Share by Region (2026-2031)
Table 21. Global Targeted Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Targeted Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 23. Global Targeted Radiopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Targeted Radiopharmaceuticals Revenue Market Share by Region (2026-2031)
Table 25. North America Targeted Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 27. North America Targeted Radiopharmaceuticals Sales by Country (2026-2031) & (K Units)
Table 28. North America Targeted Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Targeted Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Targeted Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 32. Europe Targeted Radiopharmaceuticals Sales by Country (2026-2031) & (K Units)
Table 33. Europe Targeted Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Targeted Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Targeted Radiopharmaceuticals Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Targeted Radiopharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Targeted Radiopharmaceuticals Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Targeted Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Targeted Radiopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Targeted Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Targeted Radiopharmaceuticals Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Targeted Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Targeted Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Targeted Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Targeted Radiopharmaceuticals Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Targeted Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Targeted Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Targeted Radiopharmaceuticals Sales (K Units) by Type (2020-2025)
Table 51. Global Targeted Radiopharmaceuticals Sales (K Units) by Type (2026-2031)
Table 52. Global Targeted Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 53. Global Targeted Radiopharmaceuticals Sales Market Share by Type (2026-2031)
Table 54. Global Targeted Radiopharmaceuticals Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Targeted Radiopharmaceuticals Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Targeted Radiopharmaceuticals Revenue Market Share by Type (2020-2025)
Table 57. Global Targeted Radiopharmaceuticals Revenue Market Share by Type (2026-2031)
Table 58. Global Targeted Radiopharmaceuticals Price (US$/Unit) by Type (2020-2025)
Table 59. Global Targeted Radiopharmaceuticals Price (US$/Unit) by Type (2026-2031)
Table 60. Global Targeted Radiopharmaceuticals Sales (K Units) by Application (2020-2025)
Table 61. Global Targeted Radiopharmaceuticals Sales (K Units) by Application (2026-2031)
Table 62. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 63. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2026-2031)
Table 64. Global Targeted Radiopharmaceuticals Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Targeted Radiopharmaceuticals Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Targeted Radiopharmaceuticals Revenue Market Share by Application (2020-2025)
Table 67. Global Targeted Radiopharmaceuticals Revenue Market Share by Application (2026-2031)
Table 68. Global Targeted Radiopharmaceuticals Price (US$/Unit) by Application (2020-2025)
Table 69. Global Targeted Radiopharmaceuticals Price (US$/Unit) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novartis Targeted Radiopharmaceuticals Product
Table 74. Novartis Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Targeted Radiopharmaceuticals Product
Table 79. Bayer Recent Developments/Updates
Table 80. Lantheus Company Information
Table 81. Lantheus Description and Business Overview
Table 82. Lantheus Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Lantheus Targeted Radiopharmaceuticals Product
Table 84. Lantheus Recent Developments/Updates
Table 85. Institute for Radioelements (IRE) Company Information
Table 86. Institute for Radioelements (IRE) Description and Business Overview
Table 87. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product
Table 89. Institute for Radioelements (IRE) Recent Developments/Updates
Table 90. Radiomedix Company Information
Table 91. Radiomedix Description and Business Overview
Table 92. Radiomedix Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Radiomedix Targeted Radiopharmaceuticals Product
Table 94. Radiomedix Recent Developments/Updates
Table 95. Curium Pharma Company Information
Table 96. Curium Pharma Description and Business Overview
Table 97. Curium Pharma Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Curium Pharma Targeted Radiopharmaceuticals Product
Table 99. Curium Pharma Recent Developments/Updates
Table 100. Clarity Pharmaceuticals Company Information
Table 101. Clarity Pharmaceuticals Description and Business Overview
Table 102. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product
Table 104. Clarity Pharmaceuticals Recent Developments/Updates
Table 105. ROTOP Company Information
Table 106. ROTOP Description and Business Overview
Table 107. ROTOP Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. ROTOP Targeted Radiopharmaceuticals Product
Table 109. ROTOP Recent Developments/Updates
Table 110. Ratio Therapeutics Company Information
Table 111. Ratio Therapeutics Description and Business Overview
Table 112. Ratio Therapeutics Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Ratio Therapeutics Targeted Radiopharmaceuticals Product
Table 114. Ratio Therapeutics Recent Developments/Updates
Table 115. Fusion Pharmaceuticals Company Information
Table 116. Fusion Pharmaceuticals Description and Business Overview
Table 117. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product
Table 119. Fusion Pharmaceuticals Recent Developments/Updates
Table 120. Perspective Therapeutics Company Information
Table 121. Perspective Therapeutics Description and Business Overview
Table 122. Perspective Therapeutics Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Perspective Therapeutics Targeted Radiopharmaceuticals Product
Table 124. Perspective Therapeutics Recent Developments/Updates
Table 125. RayzeBio Company Information
Table 126. RayzeBio Description and Business Overview
Table 127. RayzeBio Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. RayzeBio Targeted Radiopharmaceuticals Product
Table 129. RayzeBio Recent Developments/Updates
Table 130. Alpha-9 Theranostics Company Information
Table 131. Alpha-9 Theranostics Description and Business Overview
Table 132. Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Alpha-9 Theranostics Targeted Radiopharmaceuticals Product
Table 134. Alpha-9 Theranostics Recent Developments/Updates
Table 135. Radiopharm Theranostics Company Information
Table 136. Radiopharm Theranostics Description and Business Overview
Table 137. Radiopharm Theranostics Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Radiopharm Theranostics Targeted Radiopharmaceuticals Product
Table 139. Radiopharm Theranostics Recent Developments/Updates
Table 140. Telix Pharmaceuticals Company Information
Table 141. Telix Pharmaceuticals Description and Business Overview
Table 142. Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Telix Pharmaceuticals Targeted Radiopharmaceuticals Product
Table 144. Telix Pharmaceuticals Recent Developments/Updates
Table 145. Ariceum Therapeutics Company Information
Table 146. Ariceum Therapeutics Description and Business Overview
Table 147. Ariceum Therapeutics Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Ariceum Therapeutics Targeted Radiopharmaceuticals Product
Table 149. Ariceum Therapeutics Recent Developments/Updates
Table 150. Aktis Oncology Company Information
Table 151. Aktis Oncology Description and Business Overview
Table 152. Aktis Oncology Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Aktis Oncology Targeted Radiopharmaceuticals Product
Table 154. Aktis Oncology Recent Developments/Updates
Table 155. Navidea Biopharmaceuticals Company Information
Table 156. Navidea Biopharmaceuticals Description and Business Overview
Table 157. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product
Table 159. Navidea Biopharmaceuticals Recent Developments/Updates
Table 160. Nucleus RadioPharma Company Information
Table 161. Nucleus RadioPharma Description and Business Overview
Table 162. Nucleus RadioPharma Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Nucleus RadioPharma Targeted Radiopharmaceuticals Product
Table 164. Nucleus RadioPharma Recent Developments/Updates
Table 165. SmartNuclide Biopharma Company Information
Table 166. SmartNuclide Biopharma Description and Business Overview
Table 167. SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. SmartNuclide Biopharma Targeted Radiopharmaceuticals Product
Table 169. SmartNuclide Biopharma Recent Developments/Updates
Table 170. TetraKit Technologies Company Information
Table 171. TetraKit Technologies Description and Business Overview
Table 172. TetraKit Technologies Targeted Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. TetraKit Technologies Targeted Radiopharmaceuticals Product
Table 174. TetraKit Technologies Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Targeted Radiopharmaceuticals Distributors List
Table 178. Targeted Radiopharmaceuticals Customers List
Table 179. Targeted Radiopharmaceuticals Market Trends
Table 180. Targeted Radiopharmaceuticals Market Drivers
Table 181. Targeted Radiopharmaceuticals Market Challenges
Table 182. Targeted Radiopharmaceuticals Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Targeted Radiopharmaceuticals
Figure 2. Global Targeted Radiopharmaceuticals Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Radiopharmaceuticals Market Share by Type: 2024 & 2031
Figure 4. Targeted Therapeutic Radiopharmaceuticals Product Picture
Figure 5. Targeted Diagnostic Radiopharmaceuticals Product Picture
Figure 6. Global Targeted Radiopharmaceuticals Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Targeted Radiopharmaceuticals Market Share by Application: 2024 & 2031
Figure 8. Targeted Therapy
Figure 9. Targeted Diagnosis
Figure 10. Global Targeted Radiopharmaceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Targeted Radiopharmaceuticals Market Size (2020-2031) & (US$ Million)
Figure 12. Global Targeted Radiopharmaceuticals Sales (2020-2031) & (K Units)
Figure 13. Global Targeted Radiopharmaceuticals Average Price (US$/Unit) & (2020-2031)
Figure 14. Targeted Radiopharmaceuticals Report Years Considered
Figure 15. Targeted Radiopharmaceuticals Sales Share by Manufacturers in 2024
Figure 16. Global Targeted Radiopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Targeted Radiopharmaceuticals Players: Market Share by Revenue in Targeted Radiopharmaceuticals in 2024
Figure 18. Targeted Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Targeted Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Targeted Radiopharmaceuticals Sales Market Share by Country (2020-2031)
Figure 21. North America Targeted Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 22. United States Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Targeted Radiopharmaceuticals Sales Market Share by Country (2020-2031)
Figure 25. Europe Targeted Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 26. Germany Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Targeted Radiopharmaceuticals Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Targeted Radiopharmaceuticals Revenue Market Share by Region (2020-2031)
Figure 33. China Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Targeted Radiopharmaceuticals Sales Market Share by Country (2020-2031)
Figure 41. Latin America Targeted Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa Targeted Radiopharmaceuticals Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Targeted Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 47. Turkey Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE Targeted Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of Targeted Radiopharmaceuticals by Type (2020-2031)
Figure 51. Global Revenue Market Share of Targeted Radiopharmaceuticals by Type (2020-2031)
Figure 52. Global Targeted Radiopharmaceuticals Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of Targeted Radiopharmaceuticals by Application (2020-2031)
Figure 54. Global Revenue Market Share of Targeted Radiopharmaceuticals by Application (2020-2031)
Figure 55. Global Targeted Radiopharmaceuticals Price (US$/Unit) by Application (2020-2031)
Figure 56. Targeted Radiopharmaceuticals Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
